Home LiteratureArticle Details
PMID: 2458320 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.

Infection and immunity ·Vol. 56 ·No. 10 ·1988-10-00 ·Pages 2666-72

Bessen D, Fischetti VA

Abstract

A major virulence factor of group A streptococci is M protein, a surface-exposed fibrillar molecule of which there exist more than 80 distinct serological types. Antigenic variability resides largely in the amino-terminal region of M protein, whereas the carboxy-terminal half of the molecule is highly conserved among different M serotypes. We sought to determine whether mucosal immunization with conserved epitopes of M protein influences the course of mucosal colonization by group A streptococci in a mouse model. Synthetic peptides corresponding to sequences in the conserved region of M protein were covalently linked to the mucosal adjuvant cholera toxin B subunit. Mice were immunized intranasally with the peptide-cholera toxin B subunit conjugate or with cholera toxin B subunit alone and then challenged intranasally with live streptococci. Pharyngeal colonization by streptococci was measured for up to 15 days postchallenge. Mice immunized with synthetic peptides showed a significant reduction in colonization compared with the control group. The data demonstrate that immunity evoked by conserved portions of M protein influences the outcome of group A streptococcal infection at the nasopharyngeal mucosa in a mouse model.

MeSH Terms
Animals Antibodies, Bacterial/biosynthesis Antigens/immunology Antigens, Bacterial Bacterial Outer Membrane Proteins Bacterial Proteins/immunology Bacterial Vaccines/immunology Carrier Proteins Epitopes Immunoglobulin A/immunology Mice Mucous Membrane/immunology,microbiology Oligopeptides/chemical synthesis,immunology Pharynx/immunology,microbiology Species Specificity Streptococcal Infections/prevention & control Streptococcus pyogenes/immunology,pathogenicity Vaccination Vaccines, Synthetic/immunology
Chemicals
Antibodies, Bacterial Antigens Antigens, Bacterial Bacterial Outer Membrane Proteins Bacterial Proteins Bacterial Vaccines Carrier Proteins Epitopes Immunoglobulin A Oligopeptides Vaccines, Synthetic streptococcal M protein
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bessen D
Rockefeller University, New York, New York 10021.
Fischetti V A
References (30)
30 references, click to expand
  1. Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem.
    J Exp Med. 1987 Sep 1;166(3):647-56 PMID: 2442284
  2. Induction of local immunity to group A streptococci type M50 in mice by non-type-specific mechanisms.
    Acta Pathol Microbiol Immunol Scand B. 1985 Dec;93(6):401-5 PMID: 3914820
  3. Alternate complement pathway activation by group A streptococci: role of M-protein.
    Infect Immun. 1979 Dec;26(3):1172-6 PMID: 118929
  4. Isolation and characterization of the cell-associated region of group A streptococcal M6 protein.
    J Bacteriol. 1988 Jun;170(6):2618-24 PMID: 2453502
  5. Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein.
    J Exp Med. 1986 Oct 1;164(4):1226-38 PMID: 2428914
  6. Conformational characteristics of the complete sequence of group A streptococcal M6 protein.
    Proteins. 1988;3(1):60-9 PMID: 3287371
  7. A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci.
    Infect Immun. 1987 Dec;55(12):3237-9 PMID: 2445686
  8. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response.
    J Immunol. 1984 Oct;133(4):1818-24 PMID: 6470484
  9. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein.
    Nature. 1981 Jul 30;292(5822):457-9 PMID: 6166868
  10. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.
    J Immunol. 1984 Dec;133(6):2892-7 PMID: 6491278
  11. Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A Streptococcus.
    J Infect Dis. 1978 Dec;138(6):712-8 PMID: 368261
  12. Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers.
    J Clin Invest. 1973 Aug;52(8):1885-92 PMID: 4719668
  13. Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein.
    J Exp Med. 1985 Mar 1;161(3):623-8 PMID: 2579187
  14. Chemical and immunochemical studies on the receptor binding domain of cholera toxin B subunit.
    J Biol Chem. 1985 Oct 15;260(23):12528-34 PMID: 2413025
  15. Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats.
    Mol Gen Genet. 1987 May;207(2-3):196-203 PMID: 3039291
  16. Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein.
    J Exp Med. 1984 Apr 1;159(4):1083-95 PMID: 6368734
  17. M proteins of group A streptococci.
    Bacteriol Rev. 1974 Mar;38(1):57-86 PMID: 4133030
  18. Protective studies with a group A streptococcal M protein vaccine. II. Challange of volenteers after local immunization in the upper respiratory tract.
    J Infect Dis. 1975 Mar;131(3):217-24 PMID: 1092765
  19. Quantitative, single-tube, kinetic-dependent enzyme-linked immunosorbent assay (k-ELISA).
    Methods Enzymol. 1983;92:391-403 PMID: 6343771
  20. Sequence of myosin-crossreactive epitopes of streptococcal M protein.
    J Exp Med. 1986 Nov 1;164(5):1785-90 PMID: 2430047
  21. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci.
    J Exp Med. 1988 Mar 1;167(3):1114-23 PMID: 2450950
  22. Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor.
    J Biol Chem. 1986 Feb 5;261(4):1677-86 PMID: 3511046
  23. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    J Immunol. 1982 Apr;128(4):1897-902 PMID: 7037956
  24. Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface.
    Proc Natl Acad Sci U S A. 1981 Aug;78(8):4689-93 PMID: 7029524
  25. An epizootic in Swiss mice caused by a group A Streptococcus, newly designated type 50.
    Am J Hyg. 1960 Jul;72:111-9 PMID: 14402993
  26. Current knowledge of type-specific M antigens of group A streptococci.
    J Immunol. 1962 Sep;89:307-13 PMID: 14461914
  27. Homologous regions within M protein genes in group A streptococci of different serotypes.
    Infect Immun. 1986 May;52(2):609-12 PMID: 3516881
  28. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.
    Biochem J. 1978 Sep 1;173(3):723-37 PMID: 708370
  29. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.
    J Infect Dis. 1979 May;139(5):575-85 PMID: 374652
  30. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.
    J Exp Med. 1988 Jun 1;167(6):1945-50 PMID: 3290383
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1988-10-00
Pages
2666-72
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC259627
Subset
IM
Grants
NIAID NIH HHS · AI-11822 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]